Company Overview
Snapshot
Founded in December 2016 by Uri Arnin and Yizhar Floman, ZygoFix operates with 1–10 employees. The company has secured $8.96M across 4 funding rounds from 6 investors. In June 2021, ZygoFix received CE Clearance for its zLOCK Spinal Fusion System, marking a significant regulatory milestone for its core product.
Business overview
ZygoFix is a Health Tech & Life Sciences company specializing in medical devices for spinal fusion. The company has developed the zLOCK miniature 3D printed implant, a screwless solution for spinal stability that utilizes the spine's natural anatomy. This minimally invasive procedure aims to eliminate risks associated with traditional screw-based methods and can be performed in an outpatient setting, serving hospitals, clinics, and healthcare providers globally.
Strategic signal
In June 2021, ZygoFix received CE Clearance for its zLOCK Spinal Fusion System. This regulatory approval is a critical validation for the company's innovative screwless spinal fusion technology, enabling its commercialization within the European market and signaling readiness for broader adoption in orthopedic surgery.
Log in to access full profile ›Company Intelligence Q&A
- What is ZygoFix's primary product?
- ZygoFix's primary product is the zLOCK miniature 3D printed implant, a screwless spinal fusion system designed to utilize the spine's own anatomy for stability.
- When did ZygoFix receive CE Clearance for its zLOCK system?
- ZygoFix received CE Clearance for its zLOCK Spinal Fusion System in June 2021.
- Which investors participated in ZygoFix's March 2021 funding round?
- In March 2021, ZygoFix completed a funding round with participation from Agriline and ExitValley.
- When was ZygoFix founded and by whom?
- ZygoFix was founded in December 2016 by Uri Arnin and Yizhar Floman.
- Has ZygoFix conducted any 'first-in-human' trials?
- Yes, ZygoFix announced successful 'first-in-human' trials for its spinal facet joint fixation system in December 2018.